INOVIQ Blood Test Marks Ovarian Cancer Breakthrough
Inoviq Ltd (AU:IIQ) has released an update. INOVIQ Ltd has announced the successful analytical validation of its innovative blood test for ovarian ...#inoviqltd #iiq (Source: Reuters: Health)
Source: Reuters: Health - April 19, 2024 Category: Consumer Health News Source Type: news
Ovarian Cancer: Another Promising Target for Liquid Biopsy Ovarian Cancer: Another Promising Target for Liquid Biopsy
A blood test to screen for ovarian cancer is one of many new liquid biopsy assays being evaluated to screen for cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Why a New Study Dubbed India the ‘Cancer Capital of the World’
A new study has unveiled an alarming picture of declining overall health in India. The report, released by the Indian multinational healthcare group, Apollo Hospitals, found that skyrocketing cases of cancer and other non-communicable diseases across the country have now made it “the cancer capital of the world.”
[time-brightcove not-tgx=”true”]
Despite reporting more than a million new cases every year, India’s cancer rate has not yet surpassed countries like Denmark, Ireland, and Belgium, which record some of the highest cancer rates in the world. It is also currently lower than the U.S....
Source: TIME: Health - April 10, 2024 Category: Consumer Health News Authors: Astha Rajvanshi Tags: Uncategorized India Source Type: news
AI May Bring a Better Blood Test for Ovarian Cancer
WEDNESDAY, April 10, 2024 -- Using AI to track fragments of tumor-associated DNA in the blood, scientists say they may be close to an accurate test for a silent killer: Ovarian cancer.
It ' s the fifth leading cause of cancer death in the United... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 10, 2024 Category: General Medicine Source Type: news
J & J Begins Another Trial Over Claims Its Talc Causes Cancer
Phil and Bernard Matthey’s wrongful death lawsuit against Johnson & Johnson has headed to trial. The suit claims the company is responsible for selling asbestos-contaminated baby powder that caused the death of the plaintiffs’ mother. Patricia Matthey died from ovarian cancer at the age of 72 In 2019. The Mattheys’ lawsuit notes their mother had used J&J’s talc-based product for most of her life.
Attorney for the plaintiffs, Lance Oliver, told the jury that Patricia Matthey applied baby powder to her body 41,000 times over the course of 50 years. He also told the jury that J&J continued sel...
Source: Asbestos and Mesothelioma News - April 5, 2024 Category: Environmental Health Authors: Travis Rodgers Tags: Asbestos (general) Asbestos Exposure Companies johnson Legal Mesothelioma talc Talcum Powder Source Type: news
Why Heart Disease Research Still Favors Men
Published in partnership with The Fuller Project, a nonprofit newsroom dedicated to the coverage of women’s issues around the world.
Katherine Fitzgerald had just arrived at the party. Before she could even get a drink, she threw up and broke out in a sweat. “I was dizzy. I couldn’t breathe. I had heart pain,” Fitzgerald says.
She knew she was having a heart attack.
[time-brightcove not-tgx=”true”]
What she didn’t know then was that the heart attack could have been prevented. Fitzgerald, a health-conscious, exercise-loving lawyer, should have been taking statin drugs to s...
Source: TIME: Health - April 5, 2024 Category: Consumer Health News Authors: Maggie Fox Tags: Uncategorized freelance healthscienceclimate Source Type: news
Hormonal Birth Control Doesn ’ t Deserve Its Bad Reputation
Almost two-thirds of U.S. women of reproductive age use some kind of contraception, according to the latest federal data. And millions of them use methods that contain hormones, including birth control pills, intrauterine devices (IUDs), rings, implants, injections, and patches.
Although the specifics vary from method to method, hormonal birth control generally works by halting ovulation and/or changing conditions in the uterus or cervix to prevent pregnancy. And it works well: efficacy rates approach 100% when these methods are used correctly.
[time-brightcove not-tgx=”true”]
But hormonal birth control ...
Source: TIME: Health - April 3, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Evergreen Explainer healthscienceclimate Source Type: news
Doctors thought woman, 23, was pregnant but it was actually deadly cancer
"I thought I was too young to get ovarian cancer," she said. (Source: Daily Express - Health)
Source: Daily Express - Health - April 3, 2024 Category: Consumer Health News Source Type: news
Genmab Buys Ovarian Cancer Drug Developer for $1.8 Billion
(Source: Reuters: Health)
Source: Reuters: Health - April 3, 2024 Category: Consumer Health News Source Type: news
Doctors told woman cancerous cyst was pregnancy
Emma Colledge from Durham is encouraging people to be aware of the symptoms of ovarian cancer. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 31, 2024 Category: Consumer Health News Source Type: news
Ovarian Cancer Red Flags: What to Know to Quicken Diagnoses Ovarian Cancer Red Flags: What to Know to Quicken Diagnoses
Although ovarian cancer can be treated successfully if caught early, two-third women with the disease are diagnosed later in its course, when the illness is much more difficult to treat.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 28, 2024 Category: Cancer & Oncology Tags: Ob/Gyn & Women ' s Health Source Type: news
Can Minimally Invasive Surgery Match Open in Ovarian Cancer? Can Minimally Invasive Surgery Match Open in Ovarian Cancer?
Minimally invasive surgery for ovarian cancer does not appear to affect survival compared with open surgery when tumors are completely removed.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 28, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
100,000 Genomes Cancer Programme: Focus on Ovarian Cancer 100,000 Genomes Cancer Programme: Focus on Ovarian Cancer
Dr Maurie Markman discusses population-based data from the 100,000 Genomes Cancer Programme, focusing on ovarian cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 27, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Mum's 'silent killer' diagnosis after suffering bloating and loss of appetite
Christina Wilson, 71, was diagnosed with ovarian cancer after she experienced bloating and loss of appetite - she is now in remission and is urging other women to be aware of the symptoms (Source: Daily Express - Health)
Source: Daily Express - Health - March 26, 2024 Category: Consumer Health News Source Type: news
FDA Grants Mirvetuximab Full Approval for Ovarian Cancer FDA Grants Mirvetuximab Full Approval for Ovarian Cancer
Mirvetuximab soravtansine-gynx (Elahere) is approved for patients with folate receptor –alpha positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
